Potency and vulnerability: Troubled 'selves' in the context of antiretroviral therapy

Social Science and Medicine

Volumn 63, Issue 6, 2006, Pages 1586-1596

  Persson, Asha ^a   Newman, Christy ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antiretroviral drugs; Australia; Discourses of self and health; HIV; Immune system; Neoliberalism

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ;

ANTIBODY; BODY CONDITION; DISEASE TREATMENT; DISEASE VECTOR; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; MEDICINE; NEOLIBERALISM; VIRAL DISEASE; VULNERABILITY;

ABNORMAL DREAMING; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DEPERSONALIZATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; HALLUCINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNITY; INSOMNIA; IRRITABILITY; OUTCOME ASSESSMENT; PSYCHOSIS; SIDE EFFECT; SUICIDAL IDEATION; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; BENZOXAZINES; CULTURE; HIV INFECTIONS; HUMANS; IMMUNITY; INTERNAL-EXTERNAL CONTROL; OXAZINES; POLITICS; SELF CONCEPT; SICK ROLE; SLEEP;

EID: 33746321822     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2006.04.001     Document Type: Article

References (59)

1. AIDS Alert. Efavirenz effects worse than reported, study says. AIDS Alert 18 (2003) 9-10
2. Barad K. Posthumanist performativity: Towards an understanding of how matter comes to matter. Signs: Journal of Women in Culture and Society 28 3 (2003) 801-831
3. Berg M., and Akrich M. Introduction-Bodies on trial: Performances and politics in medicine and biology. Body and Society 10 2-3 (2004) 1-12
4. Blanch J., Martinez E., Rousaud A., Blanco J.-L., Garcia-Viejo M.-A., Peri J.-M., et al. Preliminary data of a prospective study on neuropsychiatric side effects after initiation of Efavirenz. Journal of Acquired Immune Deficiency Syndromes 27 (2001) 336-343
5. Body Health Resources Corporation (2004). Heard Sustiva makes you into a nutcase? TheBody: The Complete HIV/AIDS Resource, accessed at 〈http://www.thebody.com/Forums/AIDS/SafeSex/Archive/Treatment/Q157054.html〉 on 27 April 2005.
6. Bristol-Myers Squibb Company (2005). Sustiva (Efavirenz) 600 mg tablets: For use in HIV combination therapy, accessed at 〈http://www.sustiva.com〉 on 27 April 2005.
7. Carr A., and Cooper D. Adverse effects of antiretroviral therapy. The Lancet 356 9239 (2000) 1423-1430
8. Cox, S. (2000). Essay. Poz: Health, Hope & HIV, September, accessed at 〈http://www.poz.com/index.cfm?p=article&art_id=759〉 on 27 April 2005.
9. Crawford R. The boundaries of the self and the unhealthy other: Reflections on health, culture and AIDS. Social Science and Medicine 38 10 (1994) 1347-1365
10. Foster R., Olajide D., and Everall P. Antiretroviral therapy-induced psychosis: Case report and brief review of the literature. HIV Medicine 4 (2003) 139-144
11. Fumaz C.R., Muñoz-Moreno J.A., Moltó J., Negredo E., Ferrer M.J., Sirera G., et al. Long-term neuropsychiatric disorders on efavirenz-based approaches: Quality of life, psychological issues, and adherence. Journal of Acquired Immune Deficiency Syndrome 38 5 (2005) 560-565
12. Fumaz C.R., Tuldrà A., Ferrer J., Paredes R., Bonjoch A., Jou A., et al. Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. Journal of Acquired Immune Deficiency Syndromes 29 (2002) 244-253
13. Fuqua J.V. Ask your doctor about...: Direct-to-consumer prescription drug advertising and the HIV/AIDS medical marketplace. Cultural Studies 16 5 (2002) 650-672
14. Furner, V., & Kelly, M. (2000). Tell it like it is. Talkabout, 110, September-October 4.
15. Galvin R. Disturbing notions of chronic illness and individual responsibility: Towards a genealogy of morals. Health 6 2 (2002) 107-137
16. Haas D., Ribaudo H., Kim R., Tierney C., Wilkinson G., Gulick R., et al. Pharmacogenetics of efavirenz and central nervous system side effects: An adult AIDS clinical trial groups study. AIDS 18 (2004) 2391-2400
17. Haire, B. (1998). Is this tomorrow calling? New drugs new problems. Positive Living, June 1.
18. Haire, B., & Batrouney, C. (1998). Pros and Cons: Non-nucleosides versus protease inhibitors. Positive Living, May 10.
19. Haraway D. The biopolitics of postmodern bodies: Determinations of self in immune system discourse. Differences 1 1 (1989) 3-43
20. Hislop J., and Arber S. Understanding women's sleep management: Beyond medicalization-healthicization?. Sociology of Health & Illness 25 7 (2003) 815-837
21. Hoyt, G. (2000). Hail to Sustiva. Survival News-AIDS Survival Project, January, accessed at 〈http://www.thebody.com/asp/jan00/sustiva.html〉 on 6 December 2005.
22. Hoyt, G. (2004). Life after Sustiva. Survival News-AIDS Survival Project, May/June, 15(3), 8.
23. Kroll-Smith S., and Gunter V. Governing sleepiness: Somnolent bodies, discourse, and liquid modernity. Sociological Inquiry 75 3 (2005) 346-371
24. Lederer, B. (2004). The great depression. Poz: Health, Hope & HIV, February/March, accessed at 〈http://www.poz.com/index.cfm?p=article&art_id=3288〉 on 27 April 2005.
25. Lochet P., Peyrière H., Lotthé A., Mauboussin J., Delmas B., and Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Medicine 4 (2003) 62-66
26. Lupton D. Consumerism, reflexivity and the medical encounter. Social Science & Medicine 45 3 (1997) 373-381
27. Lupton D. Archetypes of infection: People with HIV/AIDS in the Australian press in the mid-990s. Sociology of Health and Illness 21 1 (1999) 37-53
28. Machon, K. (1999). The true believer. Positive Living, September 4-5.
29. Machon, K. (2000). The big sleep: Why do I feel so tired? Positive Living, May-June 4-5.
30. Machon K., and Batrouney C. An A-Z of side effects. HIV Herald 8 5 (1999) 9-18
31. Martin E. The end of the body?. American Ethnologist 19 1 (1992) 121-140
32. Martin E. Flexible bodies: Tracking immunity in American culture from the days of polio to the age of AIDS (1994), Beacon Press, Boston
33. Marzolini C., Telenti A., Decosterd L.A., Greub G., Biollaz J., and Buclin T. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS 15 1 (2001) 71-75
34. Meadows R. The 'negotiated night': An embodied conceptual framework for the sociological study of sleep. The Sociological Review 53 2 (2005) 240-254
35. Molina J.-M., Ferchal F., Rancinan C., Raffi F., Rozenbaum W., Sereni D., et al. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. The Journal of Infectious Diseases 182 2 (2000) 599-602
36. Monaghan L.F. Discussion piece: A critical take on the obesity debate. Social Theory & Health 3 4 (2005) 302-314
37. Newman C. Healthy, wealthy and globalized? Reader letters to Australian Men's Health magazine. Continuum: A Journal of Media & Cultural Studies 19 (2005) 299-313
38. Newman C. Sex, drugs and bad poetry: Editing Sydney's community health magazines. Journal of Australian Studies 84 (2005) 109-116
39. Newman C., Persson A., and Ellard J. 'We just don't know': Ambivalence about treatment strategies in the Australian community-based HIV media. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 10 2 (2006) 191-210
40. Novas C., and Rose N. Genetic risk and the birth of the somatic individual. Economy and Society 29 (2000) 485-513
41. Núňez M., de Requena D.G., Gallego L., Jiménez-Nácher I., González-Lahoz J., and Soriano V. Higher efavirenz plasma levels correlate with development of insomnia. Journal of Acquired Immune Deficiency Syndromes 28 (2001) 399
42. Persson A. Incorporating pharmakon: HIV, medicine and body shape change. Body and Society 10 4 (2004) 45-67
43. Persson A. Facing HIV: Body shape change and the (in)visibility of illness. Medical Anthropology 24 3 (2005) 237-264
44. Persson A., Fogarty A., Rawstorne P., and Prestage G. Northern exposure: HIV in the Northern Rivers region: A joint report (2005), National Centre in HIV Social Research, the University of New South Wales, Sydney
45. Persson A., Race K., and Wakeford E. HIV health in context: Negotiating medical technology and lived experience. Health 7 4 (2003) 397-415
46. Petersen A. Risk, governance and the new public health. In: Peterson A., and Bunton R. (Eds). Foucault, health and medicine (1997), Routledge, London 189-206
47. Petersen A., and Lupton D. The new public health: Health and self in the age of risk (1996), Allen & Unwin, St. Leonards, NSW
48. Pound P., Britten N., Morgan M., Yardley L., Pope C., Daker-White G., et al. Resisting medicines: A synthesis of qualitative studies of medicine taking. Social Science & Medicine 61 1 (2005) 133-155
49. Rimke H.M. Governing citizens through self-help literature. Cultural Studies 14 1 (2000) 61-78
50. Rose N. Governing the enterprising self. In: Heelas P., and Morris P. (Eds). The values of the enterprise culture (1992), Routledge, London 141-164
51. Rose N. Government, authority and expertise in advanced liberalism. Economy and Society 22 3 (1993) 283-299
52. Rosello M. Pictures of a virus: Ideological choices and the representation of HIV. French Cultural Studies 9 27 (1998) 337-349
53. Rosengarten M. Consumer activism in the pharmacology of HIV. Body and Society 10 1 (2004) 91-107
54. Shildrick M. Vulnerable bodies and ontological contamination. In: Bashford A., and Hooker C. (Eds). Contagion: Historical and cultural studies (2001), Routledge, London and New York 153-167
55. Sontag S. AIDS and its metaphors (1990), Doubleday, New York
56. Spire, B., Carrieri, P., Garzot, M.-A., L'Henaff, M., Obadia, Y., & the TRT-5 Group (2004). Factors associated with efavirenz discontinuation in a large community-based sample of patients. AIDS Care, 16(5), 558-564.
57. Treichler P. AIDS, homophobia, and biomedical discourse: An epidemic of signification. In: Crimp D. (Ed). AIDS: Cultural analysis, cultural activism (1991), The MIT Press, Cambridge and London 31-70
58. Waldby C. AIDS and the body politic: Biomedicine and sexual difference (1996), Routledge, London, New York
59. Williams S.J. Sleep and health: Sociological reflections on the dormant society. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 6 2 (2002) 173-200